Hepatocellular CarcinomaPhase 1NCT05003895
CAR-T cell
GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies
Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer
What the film says
This trial is for adults with advanced biliary tract cancer, including cholangiocarcinoma, who do not qualify for surgery.
The idea: add two treatments to standard chemoimmunotherapy with gemcitabine, cisplatin and durvalumab. One tumor gets a single dose of spatially fractionated radiation, then two sessions of deep hyperthermia, which heats the tumor.
This phase 1 study plans 15 patients and measures serious side effects and whether heating reaches its target. At the University of Maryland in Baltimore, Jason Molitoris leads it.
Public record; not medical advice.
Sources behind this film
Adults; advanced biliary tract cancer incl. cholangiocarcinoma, not surgical; Added to standard gemcitabine, cisplatin, durvalumab; One lesion: single SFRT dose, then two deep hyperthermia sessions; Phase 1; 15 patients; serious side effects and heating target (+1 more lines)
The drug
Administered to 1 measurable lesion on cycle 2-day 1
Deep hyperthermia alone will be delivered to the same lesion on cycle 3-day 1 and cycle 4-day 1
For this study, the drugs Gemcitabine, Cisplatin, and Durvalumab will be used. Chemoimmunotherapy will be delivered over 4 cycles for this study and can continue longer if the treating physician decides this is appropriate. Each cycle will last 3 weeks. Spatially fractionated radiation therapy (SFRT) SFRT is a form of radiation therapy that gives a single large dose of radiation to large tumors or tumors that do not qualify for surgery.
The study
This study is being done to see if the investigators can improve the outcome of patients with biliary tract cancer that do not qualify for surgery. This study will compare the effects, good and/or bad, of using a combination of standard of care chemoimmunotherapy, with the addition of radiation and deep hyperthermia.
In this study, participants will be receiving standard of care chemoimmunotherapy (gemcitabine, cisplatin, and durvalumab), radiation (spatially fractionated radiation therapy), and deep hyperthermia. Chemoimmunotherapy Chemoimmunotherapy is when chemotherapy drugs are combined with immunotherapy drugs. Chemotherapy uses different drugs to kill or slow the growth of cancer cells, whereas immunotherapy drugs are used to help the immune system attack cancer cells.
Eligibility
Inclusion criteria as written on the registry, trimmed. The full list, with exclusions, is on the live record.
For you, or someone you love
A complex diagnosis brings new questions every week, in a trial and out of one. Triangle keeps your whole medical file together, reads it with you in plain language, and helps you and your family decide what to ask next.
Then $9 a month. Cancel anytime.
Requested from your hospitals and clinics through the national networks. Add scans, pathology and anything on paper.
Reports explained as they come in, with lab values you can follow before treatment, during a trial and after.
Ask about your own file, and walk in with questions for your oncologist or the trial team.
Share one profile with the family helping you, and with your doctors.
Members also get a deeper analysis of their records and any sequencing data, including clinical trials that may fit, reviewed by a licensed physician before they receive it.
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.